|

senicapoc Clinical Trials

2 actively recruiting trials across 1 location

Also known as: TRAM-34

Pipeline

Early 1: 1Phase 2: 1

Top Sponsors

  • University of California, Davis1
  • Aarhus University Hospital1

Indications

  • Alzheimer's Disease1
  • Mild Cognitive Impairment1
  • Alzheimer Disease1
  • Glioblastoma1
  • Cancer1

Other1 trial

Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
Early 1

Sacramento, California1 trial

Senicapoc in Alzheimer's Disease

University of California, Davis Alzheimer's Disease Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.